Analytics
Also, US-based Pearl has received regulatory approvals to market its AI diagnostic tool for dental radiology in Australia and New Zealand.
A new AI screening tool has been trained to identify 14 of the most common retinal abnormalities.
Clinical research is set to verify the technology's effectiveness in estimating abnormal heart movements.
Also, Australia insurer nib offers free access to newly launched digital health app Snug.
In the third quarter of 2021 alone, digital health companies scored $6.7 billion across 169 deals.
The latest approval marks DreaMed’s fourth clearance from the Food and Drug Administration.
The AI medical station can generate an automated diagnosis that remote care providers can access to confirm.
It has a dashboard that renders an analysis of patient visit trends and actionable intelligence for clinic upgrades.
The tool is also able to check the lung condition of COVID-19 patients.
The AI solution automatically analyses cardiac CT scans and produces reports within 15 minutes.